Septoplasty — Cost, Top Hospitals & Success Rates | MyMedicPlus

Septoplasty is a surgical procedure performed to correct a deviated nasal septum — the thin wall of cartilage and bone that divides the nasal cavity into left and right chambers. When the septum deviates significantly to one side, it obstructs airflow, causing nasal congestion, difficulty breathing, recurrent sinusitis, snoring, and disrupted sleep.

The septum is considered deviated when the deviation is clinically significant — causing persistent nasal obstruction that impairs quality of life or predisposes to recurrent infections. Anatomical studies suggest that approximately 80% of people have some degree of septal deviation, but surgery is recommended only when symptoms cannot be controlled by medical management.

Septoplasty is performed entirely through the nostrils (endonasal approach), leaves no external scars, and is one of the most commonly performed ENT procedures worldwide. When combined with turbinate reduction, it addresses both the septal and mucosal contributors to nasal obstruction. When combined with rhinoplasty for cosmetic reshaping of the external nose, the combined procedure is termed septorhinoplasty.

Approximately 260,000 septoplasties are performed annually in the United States. The procedure has an excellent safety profile with high patient satisfaction when appropriate candidates are selected and operated on by an experienced ENT or facial plastic surgeon.

Septoplasty addresses nasal obstruction and associated symptoms caused by structural deviation of the septum:

• Deviated Nasal Septum (DNS): Displacement of the cartilaginous and/or bony septum, either congenital or acquired (post-traumatic). Causes unilateral or bilateral nasal blockage depending on the deviation pattern.
• Chronic Nasal Obstruction: Persistent difficulty breathing through one or both nostrils, unresponsive to nasal decongestants, saline rinses, or intranasal corticosteroids.
• Recurrent Sinusitis: Septal deviation narrows the ostiomeatal complex, impairing sinus drainage and predisposing to recurrent acute and chronic rhinosinusitis episodes.
• Obstructive Sleep Apnoea (Contributory Factor): Nasal obstruction increases upper airway resistance and can worsen snoring and OSA. Septoplasty may improve CPAP compliance by reducing nasal resistance.
• Epistaxis (Recurrent Nosebleeds): Turbulent airflow over a deviated septum desiccates the mucosa, causing recurrent anterior nasal bleeding from Kiesselbach's plexus.
• Anosmia/Hyposmia: Obstructed nasal airflow may impair olfaction by preventing odorant molecules from reaching olfactory receptors.
• Headache attributed to DNS: Contact points between the deviated septum and turbinates (contact headaches) can cause facial pain, though this indication remains debated.

Septoplasty is recommended for patients in whom nasal obstruction significantly impacts quality of life and fails to respond adequately to conservative management. Eligibility criteria include:

• Clinically significant DNS: Nasal endoscopy or CT scan confirming structural deviation correlating with the symptomatic side. Subjective NOSE (Nasal Obstruction Symptom Evaluation) score >55/100 indicates severity warranting surgical consideration.
• Failed medical therapy: Inadequate response to a 4–6 week trial of topical intranasal corticosteroids ± saline irrigation. Decongestant dependency is a red flag for rhinitis medicamentosa, which should be treated before surgery.
• Age >18 years preferred: Surgery is deferred until facial skeletal growth is complete (typically 16–18 in girls, 18–20 in boys) unless urgently indicated (trauma, severe obstruction).
• Non-smoker or willing to quit: Smoking impairs mucosal healing and increases the risk of postoperative crusting and infection.
• No active sinonasal infection: Surgery should be deferred until any acute rhinosinusitis is treated.
• Realistic expectations: Septoplasty corrects structural obstruction but does not change the external appearance of the nose (unless combined rhinoplasty is planned), does not cure allergic rhinitis, and may not fully resolve snoring if other contributing factors are present.

Preoperative evaluation includes anterior rhinoscopy, nasal endoscopy, and may include CT sinus imaging (non-contrast) to assess septal anatomy, turbinate hypertrophy, and sinus disease. Allergy testing is advisable when allergic rhinitis is suspected.

Septoplasty technique is tailored to the location and nature of the septal deformity. All approaches are endonasal (through the nostrils), avoiding external incisions:

Standard Septoplasty (Submucous Resection — SMR)

A hemitransfixion or Killian incision is made through the mucoperichondrium on one side of the septum. The surgeon elevates mucosal flaps off the cartilage and bone bilaterally, then removes, scores, or repositions the deviated segments. Deviated cartilage is resected (leaving a dorsal and caudal L-strut of at least 10–15 mm to maintain nasal support). The bony component (perpendicular plate of ethmoid, vomer) is fractured and repositioned or resected. Mucosal flaps are reapproximated and the septum splinted.

Endoscopic Septoplasty

Uses rigid nasal endoscopes (0°, 30° lenses) for enhanced visualisation of posterior and high septal deviations inaccessible to headlight-only surgery. Allows targeted resection of specific deviating components with greater precision and reduced mucosal trauma. Preferred for complex or revision cases.

Extracorporeal Septoplasty

Indicated for severe caudal septal deviations. The entire cartilaginous septum is removed, reshaped on a cutting board outside the nose (scored, morselised, sutured to correct deformity), and replaced as a straightened autograft. Most technically demanding technique but offers the most comprehensive correction.

Concurrent Turbinate Surgery

Inferior turbinate hypertrophy (mucosal or bony) frequently co-exists with DNS and contributes to obstruction. Turbinate reduction (submucosal diathermy, microdebrider turbinoplasty, or turbinate outfracture) is commonly performed simultaneously to optimise airway patency.

Septorhinoplasty

Combines septoplasty with functional or cosmetic rhinoplasty. Cartilage harvested during septoplasty can be used as graft material for nasal dorsum augmentation, tip refinement, or columellar support. Open (external) rhinoplasty approach is used for complex nasal reshaping.

Septoplasty, when performed for appropriate indications by an experienced surgeon, provides durable symptomatic improvement:

• Improved nasal breathing: Studies consistently show 75–90% of patients report significant improvement in nasal airflow. Objective peak nasal inspiratory flow (PNIF) and acoustic rhinometry measurements confirm anatomical improvement.
• Reduced nasal congestion and snoring: Decreased nasal resistance translates into quieter breathing and improved sleep quality for both patients and bed partners.
• Fewer sinus infections: Restoration of normal sinus drainage reduces recurrence frequency and duration of sinusitis episodes.
• Better CPAP compliance: In patients with OSA, reducing nasal resistance from DNS significantly improves tolerance to CPAP therapy pressure levels.
• Improved quality of life: NOSE score improvements of 40–60 points are routinely demonstrated in clinical trials. Patients report fewer sick days and reduced reliance on nasal sprays and decongestants.
• No visible scarring: All incisions are internal; the external appearance of the nose is unchanged (unless rhinoplasty is added).
• Day surgery / minimal downtime: Most patients are discharged the same day and return to office work within 7–10 days.

Septoplasty is generally safe, with major complications uncommon when performed by an experienced ENT surgeon. Patients should be counselled about the following:

• Septal perforation: The most feared complication; occurs in 0.5–2% of cases from bilateral mucosal tears at the same level. Small perforations may be asymptomatic; larger ones cause crusting, whistling, and recurrent epistaxis. Repair is technically challenging.
• Residual or recurrent deviation: 5–15% of patients report persistent or recurring nasal obstruction requiring revision septoplasty. Scar contracture may recur in operated cartilage.
• Epistaxis: Primary haemorrhage in the immediate postoperative period is the most common complication (2–5%). Packing or cautery is usually sufficient. Delayed bleeding (2 weeks post-op) from eschar separation may occur.
• Nasal tip or dorsal support loss: Over-resection of the dorsal or caudal L-strut can cause saddle-nose deformity or columellar retraction. Requires reconstructive rhinoplasty.
• Infection: Wound infection, abscess, or septal hematoma (accumulation of blood between mucosal flaps) are uncommon but require prompt drainage.
• Changes in smell: Transient anosmia or altered olfaction may occur during healing, usually resolving within weeks.
• Anaesthetic risks: Standard risks of general or sedation anaesthesia.
• Unsatisfactory cosmetic result: When rhinoplasty is added, asymmetry, contour irregularities, or over-resection may require revision.

Recovery from septoplasty is generally straightforward and faster than many general surgical procedures:

Immediate Postoperative (Day 0–1)

Most patients are discharged the same day or after one overnight stay. Internal silicone splints or nasal packs are placed to stabilise the septum and reduce haematoma risk. Packs are removed at 24–48 hours. Mild to moderate nasal congestion, blood-tinged mucus, and periorbital bruising are normal. Oral analgesics (paracetamol, NSAIDs) manage discomfort. Head elevation and cold compresses reduce swelling.

Week 1–2

Splints are removed at 5–7 days. Nasal saline irrigation is commenced immediately after splint removal to flush crusting and debris. Activity restrictions include avoidance of strenuous exercise, nose blowing, and contact sport. Most patients return to desk work within 7–10 days.

Weeks 3–6

Nasal congestion gradually improves as mucosal swelling resolves. Physiological airway improvement is typically noticeable by week 3. Intranasal corticosteroid sprays may be prescribed to manage residual mucosal inflammation.

Months 2–6

Full nasal remodelling and cartilage stabilisation takes 3–6 months. Subjective breathing improvement plateaus by 3 months. Rhinoplasty patients may notice ongoing changes in nasal tip shape and dorsal appearance through month 12. Follow-up endoscopy at 3 months checks healing. Exercise, swimming, and contact sports are resumed by week 6–8.

Septoplasty costs vary by country, whether turbinate reduction or rhinoplasty is combined, and hospital type:

• United States: $3,000–$12,000 (septoplasty alone); up to $15,000–$25,000 with rhinoplasty
• United Kingdom: £3,000–£7,000 (private); available on NHS with appropriate referral
• India: $600–$1,800 — Highly experienced ENT and facial plastic surgeons in Delhi, Bangalore, Chennai
• Thailand: $1,200–$3,000 — International hospitals with dedicated ENT and cosmetic surgery programs
• Turkey: $1,000–$3,500 — Popular medical tourism destination for rhinoplasty combining septoplasty
• Germany: $4,000–$10,000 — Comprehensive ENT evaluation and advanced endoscopic technique

Cost is influenced by: surgeon specialty and volume, combined procedures (turbinoplasty, rhinoplasty), anaesthesia type (general vs. sedation), hospital admission (day case vs. overnight), and inclusion of nasal splints, endoscopic equipment, and post-operative care. Patients with allergic rhinitis should also budget for allergy evaluation and desensitisation if indicated alongside surgery.

Before committing to surgery, all patients should complete a course of conservative management. The following non-surgical options provide clinically meaningful relief for many patients:

• Intranasal corticosteroid sprays: First-line pharmacological treatment. Agents such as mometasone furoate (Nasonex), fluticasone propionate (Flonase/Avamys), and budesonide reduce mucosal inflammation and turbinate hypertrophy, improving airflow. Daily use for a minimum of 4–6 weeks is required to assess response.
• Nasal saline irrigation: High-volume saline rinses (Neti pot, squeeze bottle) reduce mucosal crusting, clear secretions, and improve ciliary function. Used as adjunct or standalone in mild DNS.
• Nasal decongestants: Topical decongestants (oxymetazoline, xylometazoline) provide rapid but temporary relief. Restricted to ≤5 days use to avoid rhinitis medicamentosa (rebound congestion). Oral pseudoephedrine offers systemic decongestant effect.
• Nasal dilator strips: External adhesive strips (Breathe Right) or internal nasal dilators mechanically widen the nasal valve, improving flow. Useful for nighttime use and mild obstruction.
• Allergy treatment: Allergen avoidance, antihistamines, and subcutaneous/sublingual immunotherapy (allergy shots) reduce allergic rhinitis–related congestion. Essential when allergy is a primary driver of obstruction.
• Weight loss: In obese patients, weight reduction reduces upper airway fat deposition and improves nasal airway resistance.

If symptoms remain disabling after 6–12 weeks of optimised medical therapy, surgical evaluation is appropriate.